Published in

American Heart Association, Arteriosclerosis, Thrombosis, and Vascular Biology, 8(15), p. 1204-1210, 1995

DOI: 10.1161/01.atv.15.8.1204

Links

Tools

Export citation

Search in Google Scholar

T-Lymphocytes Affect Smooth-Muscle Cell Phenotype and Proliferation

Journal article published in 1995 by Be E. Rolfe ORCID, Jh H. Campbell, Nj J. Smith, Mw W. Cheong, Gr R. Campbell
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

Abstract The effects of rabbit T lymphocytes on rabbit aortic smooth muscle cell (SMC) phenotype and proliferation were investigated in vitro. SMCs seeded at confluent density in primary culture had a volume fraction of myofilaments (V v myo) of 49.8±2.6% after 3 days of culture, not significantly different from that of freshly dispersed cells (V v myo, 54.1±2.1%). Sister cultures of SMCs to which Concanavalin A–activated T lymphocytes or T lymphocyte–conditioned medium was added had significantly lower V v myo (35.5±2.2% and 31.6±2.3%, respectively) at the same time point. We have previously shown that a decrease in V v myo could be induced by the heparan sulfate–degrading activity of living macrophages and by commercial preparations of heparinase. While activated T lymphocytes also completely degraded heparan sulfate–rich 35 S-labeled extracellular matrix (an effect inhibited by the addition of 10 μg/mL heparin), no heparanase-like activity was detected in T lymphocyte–conditioned medium, indicating that for this cell type SMC phenotypic change is induced by a different mechanism. Incubation of the T lymphocyte–derived cytokine interferon gamma (IFN-γ) with freshly isolated rat SMCs caused a significant reduction in V v myo at day 2 in primary culture from 54.3±2.1% (control) to 35.4±3.0%. Furthermore, a neutralizing antibody specific for IFN-γ removed the effect of T lymphocytes and medium conditioned by them, thus positively identifying IFN-γ as the T lymphocyte factor responsible for this activity. T lymphocyte–conditioned medium was mitogenic for passaged (low V v myo) SMCs. Although SMC proliferation was inhibited by exogenous IFN-γ, two other T lymphocyte products, granulocyte-macrophage–colony stimulating factor and tumor necrosis factor–β, were found to stimulate proliferation, while interleukin-2 and interleukin-6 had no effect. It was concluded that T lymphocytes, by inducing SMC phenotypic change and stimulating proliferation, may play an important role in atherogenesis.